The central theme of CDART is that multiple facets of impulsivity defined by the UPPS scale of Whiteside and Lynam (2001) are related to different paths to drug use and that these paths are associated with different neurobiological mechanisms. To the extent that we can link specific behavioral tasks to these different self-report facets, animal models can be used to identify critical neural mechanisms that undedie the association between risk-related facets and drug use. A detailed understanding of the mechanisms that mediate the link between different facets of impulsivity and drug use will provide information about designing preventive interventions that target these risk-related facets. The overall goal of this preclinical project is to test two overarching hypotheses: (1) individual differences in the facets termed """"""""urgency"""""""", """"""""disinhibition"""""""" and """"""""sensation seeking"""""""" are related most strongly to problem use, escalation and initiation respectively, as operationally defined within an animal model of drug self- administration;and (2) individual differences in urgency, disinhibition and sensation seeking are related most strongly to differences in amygdala, prefrontal cortex and nucleus accumbens respectively, as measured by in vitro neurochemistry and in vivo electrophysiology.
The specific aims are to:
Aim 1 : Develop an animal model of urgency using a task similar to that developed in humans.
Aim 2 : Determine if individual differences in urgency, disinhibition and sensation seeking predict problem use, escalation and/or initiation of amphetamine self-administration, respectively.
Aim 3 : Determine if individual differences in facets of impulsivity differentially predict the ability of nondrug interventions to reduce use, escalation and/or initiation of amphetamine self-administration.
Aim 4 : Determine if individual differences in these risk-related facets of impulsivity are related to alterations in monoamine transporter function in amygdala, prefrontal cortex and/or nucleus accumbens.
Aim 5 : Determine if individual differences in these risk-related facets of impulsivity are related to altered patterns of neuronal activity in amygdala, prefrontal cortex and/or nucleus accumbens.

Public Health Relevance

Anti-drug preventive interventions may be most effective if they are designed to target those at highest nsk. The current project will explore the basic neurobehavioral mechanisms that mediate risk. The long- term goal is to translate these basic research findings into the design of targeted biologically-relevant preventive interventions that can be evaluated in field studies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
2P50DA005312-22
Application #
8356557
Study Section
Special Emphasis Panel (ZDA1-EXL-T (02))
Project Start
1992-09-30
Project End
Budget Start
2012-07-15
Budget End
2013-06-30
Support Year
22
Fiscal Year
2012
Total Cost
$308,974
Indirect Cost
$94,404
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Kaiser, Alison J; Davis, Heather A; Milich, Richard et al. (2018) Bidirectional Relations of Impulsive Personality and Alcohol Use Across Three Waves of Data Collection. Subst Use Misuse 53:2386-2393
Derefinko, Karen J; Bursac, Zoran; Mejia, Michael G et al. (2018) Rural and urban substance use differences: Effects of the transition to college. Am J Drug Alcohol Abuse 44:224-234
Riley, Elizabeth N; Davis, Heather A; Milich, Richard et al. (2018) Heavy, Problematic College Drinking Predicts Increases in Impulsivity. J Stud Alcohol Drugs 79:790-798
Roberts, Bethan; Eisenlohr-Moul, Tory; Martel, Michelle M (2018) Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology 88:105-114
Maggio, Sarah E; Saunders, Meredith A; Nixon, Kimberly et al. (2018) An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic ?6?2* antagonist r-bPiDI. Drug Alcohol Depend 193:154-161
Maggio, Sarah E; Saunders, Meredith A; Baxter, Thomas A et al. (2018) Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats. Psychopharmacology (Berl) 235:1439-1453
Peters, Jessica R; Eisenlohr-Moul, Tory A; Walsh, Erin C et al. (2018) Exploring the pathophysiology of emotion-based impulsivity: The roles of the sympathetic nervous system and hostile reactivity. Psychiatry Res 267:368-375
Weiss, Virginia G; Yates, Justin R; Beckmann, Joshua S et al. (2018) Social reinstatement: a rat model of peer-induced relapse. Psychopharmacology (Berl) 235:3391-3400
Chester, David S; Lynam, Donald R; Milich, Richard et al. (2018) Neural mechanisms of the rejection-aggression link. Soc Cogn Affect Neurosci 13:501-512
Zapolski, Tamika C B; Rowe, Alia T; Fisher, Sycarah et al. (2018) Peer victimization and substance use: Understanding the indirect effect of depressive symptomatology across gender. Addict Behav 84:160-166

Showing the most recent 10 out of 169 publications